Brief: Titan Announces Positive Results From The First Studies Of TP-2021 Implant
23/06/2021 13:34
June 23 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN ANNOUNCES POSITIVE RESULTS FROM THE FIRST STUDIES OF
TP-2021 IMPLANT IN AN ESTABLISHED ANIMAL MODEL OF CHRONIC
PRURITUS
Source text for Eikon: ID:nPn5C1hv9a
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.